2009
DOI: 10.1016/j.intimp.2009.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Polybacterial immunomodulator Respivax restores the inductive function of innate immunity in patients with recurrent respiratory infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 57 publications
0
3
0
Order By: Relevance
“…Products with immunostimulant properties have been reported to activate immune cells with receptors that recognize common bacterial products or to provide additional stimulation to activate them. 77 For instance, 2 bacterial lysates have been shown to activate TLR2, 78,79 and levamisole may do the same. 80 In another study, OM-85 induced interleukin-1beta, IL-6, and tumor necrosis factor alpha (TNF-a) in murine macrophages by activating TLR4 and TLR2 via the ERK1/2/NF kappa B pathway.…”
Section: Discussionmentioning
confidence: 99%
“…Products with immunostimulant properties have been reported to activate immune cells with receptors that recognize common bacterial products or to provide additional stimulation to activate them. 77 For instance, 2 bacterial lysates have been shown to activate TLR2, 78,79 and levamisole may do the same. 80 In another study, OM-85 induced interleukin-1beta, IL-6, and tumor necrosis factor alpha (TNF-a) in murine macrophages by activating TLR4 and TLR2 via the ERK1/2/NF kappa B pathway.…”
Section: Discussionmentioning
confidence: 99%
“…90% of patients taking three months of sublingual bacterial preparation MV140, consisting of four common inactivated uropathogens for recurrent urinary tract infections, were protected from relapse infections, while every patient prescribed six months of prophylactic antibiotics experienced relapses [78]. Patients with chronic, recurrent respiratory infections have lower surface expression levels of TLR2 and CD14 on their circulating monocytes, but oral administration of Respivax, a formulation of six respiratory pathogens, restores these levels to match the healthy controls [79], demonstrating trained immunity-like effects. In vitro stimulation with polyvalent bacterial lysate, prepared with six common respiratory pathogens, induced dose-dependent production of NO in murine alveolar macrophages and increased transcription of pro-inflammatory chemokines and cytokines, NO synthase, and antimicrobial peptides in human epithelial cells [80].…”
Section: Future Directions In Exploiting Trained Immunitymentioning
confidence: 99%
“…In India, an ether extract of metabolites of nine bacteria, namely ß‐streptococcus , Staphylococcus albus , Staphylococcus aureus , Escherichia coli , Haemophilus influenza , Moraxella catarrhalis , Salmonella typhi (standard O & H), Salmonella paratyphi (A & B), and Diptheroid bacilli, combined with bile lipids is marketed as Sterodin (Union Drug Co. Ltd., Kolkata, India) and has been licensed as an immunostimulatory preparation . According to several published studies, extracts from these bacterial species used individually or in different combinations have proved to be potent immune‐stimulators . The contents of each extract depend on the method of its preparation.…”
mentioning
confidence: 99%